Insulin costs for Medicare beneficiaries are capped at $35 per month under the Inflation Reduction Act

IRA insulin price cap of $35/month becomes effective for all Medicare Part D beneficiaries (Part B cap was effective since 2023). Affects ~3.3 million Medicare enrollees who use insulin, saving an average of $500/year per beneficiary.